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1482Objective: Pacemaker and implantable cardioverter defibrillator lead endocarditis mandates removal of all
foreign material. In supposedly limited (pocket) infections, such a radical approach is still controversial.
Thus, some patients are potentially exposed to persistent and recurrent infection because of retained material.
Procedural risks and the success of eradicating infection were examined if involvement of the complete system
was assumed in any cardiovascular implantable electronic device infection and complete removal was thus
mandatory.
Methods: A 12-year experience with 192 consecutive cases of bacterial pacemaker (152) or defibrillator (40)
infections is presented. Complete removal of all prosthetic material was always aimed for. This was followed
by antibiotic treatment for 4 to 6 weeks under temporary pacing if required, and then the new system was
implanted. A total of 104 parameters concerning patient characteristics and operative and postoperative
treatment were examined for their influence on outcome.
Results: Infection was eradicated in 92.8% of patients. Recurrence was predominantly caused by failure to
remove all prosthetic material (P< .001). If the protocol was strictly followed, infection was eradicated in
97.4% of patients. Conversely, 71.4% of patients with retained material showed recurrence. Further risk factors
were poor dental hygiene and evidence of chronic subclinical infection. Morbidity and mortality of the interven-
tional and open procedures were low. Open lead extraction was performed primarily in 34 patients (17.7%) and
secondarily in 3 patients (1.9%). Temporary pacing and long-term antibiotic treatment were well tolerated.
Conclusions: Complete removal of prosthetic material in any cardiovascular implantable electronic device
infection is safe and associated with low morbidity and mortality. Success of eradicating infection is high if
all system components are removed. Temporary pacing in dependent patients may be performed safely on an
outpatient basis. (J Thorac Cardiovasc Surg 2011;142:1482-90)The incidence of bacterial infections of cardiac pace-
makers and defibrillators (cardiovascular implantable elec-
tronic devices [CIEDs]) has increased1,2 independently of
changing patient characteristics and the growing relative
proportion of implantable cardioverter defibrillator (ICD)
recipients.1 This continuing trend requires rigorous man-
agement strategies.3-5 Risk factors for the development of
CIED infection have repeatedly been identified.5-13 Renal
failure,6,14,15 diabetes and congestive heart failure,6,14 the
number of previous operations,2,6,14,16 increasing number
of leads,16 indwelling central venous lines,16 experienced
bacteremias,17 and thrombosis on the leads10,18 all
predispose to later infection, whereas steroid treatmente Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery,a
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The Journal of Thoracic and Cardiovascular Surremains controversial.15 The experience of the physician
performing the procedure and the circumstances of implan-
tation (eg, catheter laboratory vs operating room) have
been discussed,19 but conclusive data are lacking. Current
focus is on prevention by avoidance of known risk
factors and prophylactic perioperative antibiotics13(meta-
analysis20) on the one hand and optimized treatment of
established infection on the other.
For the treatment of proven septicemia or lead endocardi-
tis, there is sufficient evidence to support obligatory re-
moval of all prosthetic material under continued antibiotic
therapy6,18,19,21-26 (North American Society of Pacing and
Electrophysiology/Heart Rhythm Society).11,19 Antibiotic
treatment alone has been abandoned in this context.7,19,22,25
However, removal of system components with, eg, the leads
left in place supposedly isolated pocket infections, although
repeatedly criticized,9,25,27 is still performed, and current
recommendations do not categorically object to this.19 There
also has been a revival of intermediate procedureswith irriga-
tion andmuscle flaps as an alternative to complete removal.28
The definition of limited infection, especially in the absence
of diagnostic tools, creates the dilemma.29,30 An additional
dispute is about whether to implant the new permanent
system at the same time or after a period of temporarygery c December 2011
Abbreviations and Acronyms
CIED ¼ cardiovascular implantable electronic
device
CRP ¼ C-reactive protein
ESR ¼ erythrocyte sedimentation rate
ICD ¼ implantable cardioverter defibrillator
MRSA ¼ methicillin-resistant Staphylococcus
aureus
Pichlmaier et al Acquired Cardiovascular Diseasepacing and antibiotic treatment.2,4,21,26,31,32 In pacemaker-
dependent patients and patients with class I indications for
ICD treatment, this is a management and cost issue.
In 1996, the current authors began to treat consecutive
patients with any CIED infection as if there was always
lead involvement, and thus complete removal of all pros-
thetic material was mandatory in every case. The protocol
included 3 to 6 weeks of antibiotic treatment and temporary
pacing (if necessary) between extraction and reimplanta-
tion, as others have since advocated.31,32 The
retrospective analysis of this prospectively collected data
set was performed to examine if such a rigorous approach
achieves adequate results with acceptable morbidity and
mortality without the problem of having to distinguish
between various forms of CIED infection.A
C
DMATERIALS AND METHODS
Patients and Preoperative Investigations
Patients treated from 1996 to 2007 for CIED infection were included af-
ter giving informed consent (Declaration of Helsinki) for the use of their
data. The diagnosis was based on local changes of the device pocket,
C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and the
Duke criteria for endocarditis.4,6,26 Recurrent device dislocations where
1 or more corrective procedures had been performed qualified as chronic
infection once obvious causes had been excluded. Vegetations were
primarily treated with intravenous antibiotics and anticoagulation to
reduce size and microbial load. Thereafter, vegetations larger than 1 cm
or definite valvular involvement led primarily to open surgery (Figure 1).
Devices were interrogated to estimate the degree of dependence and in-
trinsic rhythm challenged by programming to ventricular demand mode
(VVI) 30 beats/min, including the use of sympathomimetic drugs. If less
than 10% pacing per 24 hours was documented, temporary pacing was
not primarily planned in these patients. Stratification into therapy regimens
followed (Figure 1).
Surgical Procedures
All procedures were performed by a cardiovascular surgeon in an oper-
ating room using a conventional mobile C-arm. Pacemaker-dependent
patients received a temporary transcutaneous transvenous pacing system,
which has since been described by others.31,32 Bipolar active fixation
leads (Medtronic Inc. [Minneapolis, Minn] 4076/5076, 58 or 65 cm)
were introduced preferably ipsilateral to the infected device via the
subclavian/jugular vein, leaving the contralateral side for implantation of
the permanent device. Exceptions were made if the inflammatory
response around the device pocket was large and could not be
circumvented with the temporary lead. After endocardial positioning, theThe Journal of Thoracic and Carproximal part of the lead was tunneled subcutaneously 15 to 25 cm
parallel to the sternum and externalized. The lead was secured on the
deep fascia at both sites using nonresorbable sutures. A pacemaker
programmed to bipolar function was connected externally to the lead.
Extensive debridement (all scar tissue and fibrous capsule) followed at
the site of the device pocket. Swabs were taken for microbiological
workup. Removal of leads was achieved using Byrd dilator sheaths
(Cook Medical, Bloomington, Ind) in combination with locking stylets
(VascoExtor, VascoMed, Binzen, Germany, or Spectranetics, Colorado
Springs, Colo) when necessary. Proximal adhesions were primarily
addressed with passive sheaths alone. The regular positioning stylet was
exchanged for a locking stylet if stabilization became insufficient or
distal adhesions became apparent. Locking stylets were primarily used
without sheaths if only distal adhesions were encountered.
Electrosurgical sheaths (Cook Medical) have lately (since 2005)
facilitated extraction in cases of severe adhesions. The lead extraction
approach was always along the implant vein. Other approaches were not
used in infection. Extraction was thought to be safer and thus
approached more forcefully if patients had undergone previous
conventional cardiac surgery. Development of effusions is less common
because of the adhesions, and the alternative open procedure carries
a substantially higher risk.
Open surgery was performed through a median sternotomy with cardio-
pulmonary bypass using cardioplegic arrest as required for concomitant
procedures. The right atrium was opened, and the damage of the tricuspid
valve was assessed; if required, repair was attempted whenever possible.
The leads were cut in the superior vena cava, and the distal portion was
explanted. The device pocket and proximal lead segments were attended
to at the end after closure of the sternotomy. Extraction sheaths were
used as required to free the lead remnant from adhesions under the clavicle
(1 case). Temporary pacing was achieved via epicardial temporary pacing
wires. Some patients received epicardial permanent pacing wires at the di-
gression of the surgeon. Electrode tips underwent microbiological evalua-
tion applying an extended endocarditis protocol.
Primary wound closure of the device pocket was always attempted us-
ing resorbable monofilament sutures for both subcutaneous fascia and skin.
This followed radical resection of the complete device pocket and all asso-
ciated scar tissue, including the muscle fascia. Suction drains were placed
and left for 5 days. Antibiotic treatment was not started until the time of
operation except in sepsis or if patients were already receiving endocarditis
treatment (vegetations) to increase the yield of microbiological examina-
tion of the intraoperative samples. A broad-spectrum cephalosporin was
given, and the treatment was adjusted according to susceptibility. Intrave-
nous administration was changed to oral, excluding patients with valvular
endocarditis, after 3 to 7 days. Antibiotic treatment was continued for 3 to 6
weeks depending on the microbiological culture results (positive lead tip 6
weeks, negative lead tip 3 weeks). These comparatively long intervals were
chosen in 1996 with reference to the treatment of valvular endocarditis be-
fore surgical valve replacement (6 weeks minimum). If microbiological
culture from the leads remained negative, the interval was empirically
halved to avoid potential complications of prolonged antibiotic therapy.
Patients with a pacemaker were discharged if possible; patients with an
ICD more often remained as inpatients on telemetry. Currently, patients
with no shock history and with a primarily prophylactic indication are
also discharged. In the absence of systemic infection (ESR/CRP), patients
then received a new permanent pacemaker/ICD on the contralateral side.
Antibiotic treatment was continued for a further 2 to 3 weeks. Follow-up
was at 6 weeks. With the use of questionnaires, long-term follow-up was
performed by telephone interview of the patient, family practitioner, and
cardiologist.Study Design and Statistics
Analyses and graphs were performed using MedCalc2.4.0 (Marien-
kerke, Belgium). Categoric variables are presented as percentages, anddiovascular Surgery c Volume 142, Number 6 1483
FIGURE 1. Treatment protocol with stratification of patients into interventional removal or open surgery. PM, Pacemaker; ICD, implantable cardioverter
defibrillator; TTE, transthoracic echocardiography; TEE, transesophageal echocardiography.
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dians (ranges) as appropriate (Kolmogorov–Smirnov test). Categoric data
were examined with Pearson’s chi-square test. Normally distributed contin-
uous variables were compared with the t test for independent variables, and
not-normally distributed data were compared with the Mann–Whitney test.
Homogeneity of variances was investigated by Levine’s test. Freedom from
recurrence of infection was analyzed using the Kaplan–Meier method
(log-rank test).
The primary end point was the failure to eradicate infection (‘‘recur-
rence’’). A total of 104 parameters relating to patient characteristics,
presenting clinical picture, surgical details, and postoperative course
were analyzed for their relevance. Mortality, short- and medium-term
morbidity, technical aspects of the surgery, and acceptance of the treat-
ment protocol were secondarily evaluated. A Cox proportional hazard
model including all parameters (pre-, intra-, and postoperative) was
used to estimate relative risk for recurrence of infection. Parameters
with less than 10 events were excluded from the proportional hazard
regression model.RESULTS
Patient Characteristics
From November 1996 to July 2007, 3491 surgical proce-
dures involving CIEDs were performed. Infection was pre-
operatively diagnosed in 178 patients (mean age 69 years,
27% were female) who underwent 192 procedures. Thus,
12 patients underwent 2 or 3 procedures (Figure 2). The ma-
jority of patients (119) were referred from other hospitals,
35 with recurrent/persistent infection. One third of patients
(57) had undergone surgical procedures in which old leads1484 The Journal of Thoracic and Cardiovascular Surhad been abandoned. In 124 patients (69.7%), there had
been 2 (1–5) surgical interventions on the pocket since im-
plantation. In 32.3% of patients, at least 1 surgical interven-
tion was to deal with complications rather than battery
depletion (67.7%).
In 133 procedures (69.3%), an isolated pocket problem
was suspected (53 showed purulent secretion). Pocket revi-
sions elsewhere had preceded presentation in 65 patients,
and 15 patients exhibited a minor problem, such as persis-
tent pain, skin irritation, or recurrent dislocation of the
device with secondary confirmation of infection on micro-
biological workup. The remaining 59 patients were referred
with lead endocarditis secured echocardiographically (51)
or by blood cultures (53). Vegetations varied from 0.5 to 4
cm. Tricuspid insufficiency was found in 25% of patients.
Only 3 patients had isolated serologic or clinical evidence
of some form of ongoing systemic infection without
a secured diagnosis.
Retrospectively, CRP/ESR only marginally influenced
surgical decision-making at the stage of primary admission.
Thus, elevated levels were observed in cases of obvious lead
endocarditis or acute postoperative pocket infections but
were absent in cases of recurrent device dislocations.
Procedures
Details of the procedures performed are shown in Table 1
and Figure 2. All open procedures were primarily performedgery c December 2011
FIGURE 2. Treatment pathways and outcome of patients. Three patients (in circle) crossed over primarily from interventional removal (number of
procedures) to open surgery (number of procedures) because of retained material.
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procedures in this group reflects patient comorbidity and
the policy to attend to correctable cardiac problems if bypass
is required for lead removal whenever possible.
Complete removal of all prosthetic material was primar-
ily achieved in 165 patients (92.7%). Three patients pro-
ceeded directly to secondary open procedures because of
failure to remove all material interventionally (Figure 2).
Retained material in addition to leads included remnants
of the lead insulation. Open operations also led to secondary
procedures. In 3 cases, lead remnants were inadvertently
left in the access vein proximally.
In 190 cases (99%), primary wound closurewas possible,
including 4 rotational skin flaps. In all these instances, the
wound healed completely without the need for further inter-
vention. Evidence for ongoing soft tissue infection or undue
secretions via the drainage canal led to operative revisions
in 2 cases (Table 1).
Implantation of the new permanent device followed after
a median time interval of 6 (1–47) weeks. Long interim pe-
riods arose where no new permanent device was implanted
because the indication was questionable, but later the pa-
tient required a pacemaker again. Elevated CRP/ESR at
this stage led to a delay of reimplantation.
Outcome
Follow-up was 55 (24–156) months with an obligatory
minimum of 24 months.The Journal of Thoracic and CarMortality. Thirty-three patients died (CIED-related in 7,
cardiac reasons in 12, other reasons in 14). Of the 7
(3.9%) CIED infection-related deaths, 3 (1.7%) followed
open operations within 30 days because of ongoing valvular
endocarditis or the operation (Figure 2). Four patients died
after interventional procedures (Figure 2), 2 within 30 days
and 2 later. The 2 early deaths after successful transvenous
removal of all material were due to ongoing uncontrolled
endocarditis (methicillin-resistant Staphylococcus aureus
[MRSA] in 1 and extensive 3-valve involvement in 1). No
patient died after a secondary open operation after a failed
transvenous extraction. The cause of death is not known in
2 patients, but deaths occurred more than 2 years after
surgery.
Recurrence of infection. Fourteen cases (7.8%) of recur-
rence were observed (Figure 2). They presented 1 to 14
months after surgery with signs of infection, vegetations
on the remaining/new leads, or tricuspid valve endocarditis,
and reentered the treatment protocol accordingly (1 patient
twice).
The single most significant, independent parameter for
recurrence was incomplete removal of prosthetic material
in 10 cases 71.4% (Figure 3). Reasons for failure to imme-
diately perform another procedure in these patients to sat-
isfy the protocol were (1) leaving the leads in patients
with primary pocket problems and very high risk for the
removal procedure (5 patients); (2) leaving torn leads in pa-
tients with high risk (2 patients); and (3) leaving intravenousdiovascular Surgery c Volume 142, Number 6 1485
TABLE 1. Procedures performed and general details
Parameter No. Fraction/range
Open surgery (n ¼ 37)
Operation time 165 min 36–600 min
Bypass time 65 min 15–161 min
Aortic clamp time 39 min 5–119 min
Postoperative ventilation 11.5 h 3–564 h
Hospital stay 16.1 d 9–31 d
Additional cardiac procedures TVR 41.6%, AVR 16.7%, ASD
closure 8.3%, MVR 4.2%, CABG
4.2%, combinations thereof 25%
Interventional procedures (n ¼ 155):
General anesthesia 133 85.8%
Procedure time 60 min 12–240 min
X-ray exposure 4.8 min 0–43 min
Age of leads 60 mo (1–330 mo)
(23%<1 y implanted)
Locking stylets (procedures) 75 48%
Dilator sheaths (procedures) 52 34%
Morbidity:
Valve damage requiring TVR 2 1%
Soft tissue infection
requiring surgery
2 1%
Hematoma requiring surgery 9 4.7%
Hematoma not requiring surgery 9 4.7%
Pericardial effusion not
requiring drainage
4 2.1%
Access vein thrombosis 3 1.6%
TVR, Tricuspid valve repair; AVR, aortic valve replacement; ASD, atrial septal defect;
MVR, mitral valve replacement; CABG, coronary artery bypass graft. Details about
the operations performed and associated overall morbidity are summarized and
expressed in absolute numbers and percentages of the relevant subpopulation.
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patients). These eventually led to further surgery (interven-
tional in 8 patients, open in 2 patients) with complete
removal of retained material, and infection then resolved
(Figure 2).
Because of refusal to consent (2 patients) or excessive
procedural risk (2 patients), a further 4 patients did not
have all prosthetic material removed. Only 2 patients re-
main without symptoms (at 29 and 69 months), and 2 pa-
tients have died of sepsis at 1.5 and 84 months, although
they initially presented with a presumed isolated pocket
infection (Figure 3).
Three secondary interventional procedures and 1 open
operation were necessary to deal with recurrence despite
primary successful complete removal of all prosthetic mate-
rial (2.4%) (Figure 3). Two of these (50%) followed sup-
posedly isolated pocket infections. The overall secondary
success rate of eradication of infection once all prosthetic
material was removed was 97.4%.
Factors associated with failure to eradicate infection are
shown in Table 2. Two parameters (incomplete removal of
artificial material 10/4 and cessation of CIED therapy1486 The Journal of Thoracic and Cardiovascular Sur0/14) had to be excluded from the Cox model because there
were less than 10 events in one of the groups. They were
evaluated using the Kaplan–Meier method. Conversely,
Table 3 shows a selection of parameters that did not reach
significance but might have been expected to. Data com-
pleteness for the set of 104 parameters was 99.1%.
A recurrence of infection or late lead failure did not de-
velop in any of the 25 patients who received permanent
epicardial leads during an open procedure. Figure 4 shows
an example of a failed interventional lead removal after
an attempt at extraction at another institution, and eventu-
ally an open procedure had to be performed.
Morbidity of the procedures. Cardiac tamponade or ve-
nous tears did not occur. Further complications are summa-
rized in Table 1.
Patients’ acceptance. The hospital stay for patients with
a pacemaker was 7 (2–71) days primarily because drains
are not removed before postoperative day 5 and the micro-
biological workup may take 7 days. Patients with an ICD
stayed in the hospital for 12 (7–46) days. In the majority
of patients, the procedure was perceived acceptable in terms
of stress, length of hospital stay, and burden of the postop-
erative antibiotic therapy. In 12% of patients, the patient or
the treating physician/cardiologist reported minor difficul-
ties with the temporary pacing or antibiotic regimen. In 9
patients (4.7%), the antibiotic was changed for diarrhea
(2), renal insufficiency (2), and skin rash or minor side ef-
fects (5). Reprogramming of the temporary devices was
necessary in 9 patients (pacemaker syndrome in 1 and
chronotropic insufficiency in 8). No case of new atrial fibril-
lation was observed. There was no dislodgement, dysfunc-
tion, or wound problem at the percutaneous passage of the
temporary lead.
Microbiology
In 81.8% of cases, bacteria were identified in culture.
Coagulase-negative staphylococci (epidermidis, capitis,
haemolyticus) were the most common organisms (54.7%)
followed by Staphylococcus aureus (27.6%) and gram-
positive rods. MRSA was observed in 3 patients. Of the
25 patients in whom no definitive diagnosis of device infec-
tion was made preoperatively, 80.6% returned a positive
culture result from intraoperative samples, predominantly
Staphylococcus epidermidis. Failure to eradicate infection
was not obviously associated with the type or presence of
organisms, and recurrent disease always yielded the same
organism.
DISCUSSION
The distinction between isolated pocket and complete de-
vice/lead involvement in bacterial CIED infection can be
difficult.27 However, treatment strategies depend on this dif-
ferentiation, and complete removal of all prosthetic material
is only recommended for lead endocarditis.8,13,19 To avoidgery c December 2011
FIGURE 3. Kaplan–Meier plot of freedom from infection dependent on complete removal of prosthetic material. Note nonlinear time axis stressing the
initial 24 months after surgery.
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the results of a radical policy of mandatory complete
removal of all prosthetic material in all cases were
examined. The results confirm acceptable mortality and
morbidity, and the recurrence rate of 2.6% is low. The
main criticism concerning this strategy to treat any CIED
infection is that a potential number of patients with no or
limited infection of their device components undergo
extensive, radical therapy. This is contrasted by the
deleterious result of patients returning with smoldering
infections on previously abandoned components.6,27 The
appropriateness of this approach may be judged after
a detailed analysis of the complication and success rates
in comparison with published data. A prospective trial
could elucidate this issue but is applicable only to patients
with ‘‘mild’’ disease.TABLE 2. Failure to eradicate infection: Significant parameters
Parameter
Chi-square
P value
Preoperative
Previous lead dislocation .04
Imminent cutaneous perforation .02
Poor dental hygiene .04
Intraoperative
Interventional removal .005
Incomplete removal of prosthetic material <.001
Postoperative
Cessation of CIED therapy .03
Contralateral implantation of permanent device .02
CI, Confidence interval; CIED, cardiovascular implantable electronic device. Prognostic c
multivariate Cox regression analysis. *Incomplete removal of prosthetic material and ces
in the text.
The Journal of Thoracic and CarComplications
The protocol has not caused unduly high complication
rates. Mortality resulted from device infection or open
operation in 3.9% and transvenous removal procedures in
2.2% (not procedure related). The significance of CIED in-
fection in causing mortality has been demonstrated,2,6 but
others have reported a higher procedural mortality.33 This
may be by chance given the heterogeneity of these patients
or may relate to a lower threshold in patients with lead en-
docarditis primarily undergoing an open procedure, which
naturally carries a higher risk. The opposite is found, how-
ever, in that the proportion of open procedures in this series
is higher than in other reports.6,26,34,35 This may be
explained by a higher incidence of valvular involvement
or concomitant cardiac disease in this patient population
who were all referred to a surgical unit. Furthermore, theCox regression
Hazard ratio 95% CI P value
3.62 1.10–11.88 .03
9.79 2.38–40.23 .001
4.25 1.12–16.04 .003
0.30 0.10–0.84 .002
Kaplan–Meier (Figure 2) <.001*
(<1.00) Kaplan–Meier .01*
0.23 0.07–0.76 .01
ovariates for recurrence of infection as identified by chi-square test and subsequent
sation of CIED therapy were assessed by log-rank test (Kaplan–Meier) as explained
diovascular Surgery c Volume 142, Number 6 1487
TABLE 3. Failure to eradicate infection: Parameters of no
significance
Parameter P value
Preoperative
Age .45
ICD/pacer .27
Latest revision in our hospital .91
No. of previous operations on the pocket .79*
Age of leads .48
Infection follows primary implantation .79
Infection follows battery replacement .83
Local infection (pocket) .90
Systemic infection (leads) .52
Combined (pocket and leads) .71
Positive inflammatory markers .91
Positive blood culture .69
Cutaneous perforation .97
Purulence .10
Positive microbiology from leads .77
MRSA .85
Severe immunosuppression .44
Cortisone therapy .81
Renal failure .38
Diabetes mellitus .76
ASA score .55*
Intraoperative
Use of extraction stylets .13y
Epicardial temporary pacing .31y
Simultaneous epicardial permanent device .71y
Valvular endocarditis .60y
Delayed permanent device .46
Ipsilateral permanent device .40
Open explantation .57
Tricuspid reconstruction .89y
Postoperative
Temporary pacing .85
Duration antibiotic treatment .63
No permanent device .72
ICD, Implantable cardioverter defibrillator;MRSA,methicillin-resistant Staphylococ-
cus aureus; ASA, American Society of Anesthesiologists. Selection of parameters not
found to be relevant for the success to eradicate infection is shown. *Chi-square test
for trend. ySubgroup analysis.
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with vegetations greater than 1 cm. The authors changed
this policy from 2008 (no patients included thereafter) so
that vegetations up to 2 cm are now accepted for
interventional removal; this seems safe and is reflected in
the most recent recommendations.19 Whether more com-
plex approaches to lead removal (eg, multivessel access33)
will further reduce the proportion of open procedures
remains speculative.
It may furthermore be argued that by applying our radical
protocol, the resulting patient population may be less sick
(higher proportion of mild disease). However, the relative
proportions of isolated pocket infections as opposed to
lead endocarditis (65/35), the patient characteristics, and1488 The Journal of Thoracic and Cardiovascular Surthe baseline mortality figures suggest this is a typical and
comparable6,26 patient cohort.
Major complications due to the interventional proce-
dures were rare in this series, with no cases of cardiac tam-
ponade or venous tears. There were 2 late tricuspid valve
repairs (1%). Damage to the valve cusps is not reported fre-
quently, and laser-assisted extraction, which was not used
for cost reasons, may offer an advantage over purely me-
chanical methods in this respect.34,35 Conversely, lethal
complications during the extraction are predominantly
known from laser-assisted extraction. Open procedures
did not cause significant major morbidity.
Secondary wound explorations were performed in 11
cases (5.7%), mainly for hematoma. All other wounds
healed primarily, and only 2 local recurrences of infection
were observed if all material had been removed. Three sub-
clavian vein thromboses (1.6%) occurred. Few studies have
specifically reported ‘‘minor’’ complication rates in the
treatment of device infection, but those reported for lead re-
moval in general are usually higher than in this series.26,33
Radical debridement of subcutaneous tissue and fascial
layers with subsequent extended suction drainage has per-
mitted primary wound closure and proven highly effective
in this series, but there are little data with which to compare.
Eradication of Infection
Published series demonstrate a high success rate of erad-
icating infection with slightly different approaches, more
conservative patient selection, and a shorter minimum
follow-up.2,26,33 Extraction of all prosthetic material is
essential, because remnants, even parts of the outer lead
insulation, caused recurrence in 71.4%, which was
suspected by others.2,24,26
Prolonged antibiotic treatment2 is thought to be important,
but thedata presentedcannot prove this, and it is thepractice in
other institutions to interpose only days before reimplanta-
tion.19 It has been suggested that lead age and the extent of en-
docarditic involvement of the leads may change the
requirement for prolonged antibiotic therapy.6,36 Recurrence
in this series was independent of the type of infection
(pocket/leads and bacterial strain), but in support of the
former suggestion, it was associated with evidence of
a chronic infectious process (previous lead dislocation and
imminent cutaneous perforation) and the patient’s dental
status. The latter is a new finding; however, in analogy to
infective endocarditis is not entirely surprising.6 The absence
of prosthetic material in patients who did not receive another
permanent device and a contralateral implantation site far
from the old pocket as negative predictive factors for recur-
rence further support the argument. Thus, an absence of
a source of bacteremias on the one hand and an absolute or rel-
ative absence of a target site on the other are expected to result
in a lower reinfection rate.Again, this has not been specifically
addressed in the literature but seems reasonable to conclude.gery c December 2011
FIGURE 4. Persistent infection after limited explantation (A, B) in a patient. Intraoperative view from the patient’s right (surgeon’s view) into the right
atrium showing the torn leads with vegetations (C) and the vicinity of the tricuspid valve (D). CS,Coronary sinus; RV, right ventricle; RA, right atrium; SVC,
superior vena cava; IVC, inferior vena cava.
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Positive culture results were observed in 80.6% of pa-
tients in whom the preoperative diagnosis of infection was
unsecured, confirming that the clinical suspicion is usually
justified. Also, the bacteria isolated were much as ex-
pected.36 No direct correlation was found between the strain
and the failure to eradicate infection, although this had been
expected according to the literature.6,37,38 This may be seen
as supportive of a prolonged antibiotic regimen, despite the
fact that it was not possible to show a direct correlation
between the duration of interim antibiotic therapy and the
success of eradication. Selection of resistance may be an
issue in this case,36 but no evidence of recurrence with dif-
ferent, more resistant bacteria was found and only 3 cases of
MRSAwere observed in this series, in which 1 patient died
of endocarditis. This may be an issue about changing the
antibiotic prophylaxis in CIED surgery for the future, as
has been proposed.19,36 The North American Society of
Pacing and Electrophysiology/Heart Rhythm Society
statement19 supports a radical approach but advocates
a shorter period of interim antibiotic treatment without
exactly specifying this (level of evidence C).Safety
Device and lead removal has been shown to be safe in
different patient cohorts.11,25,26,32,39 The details of the
procedures, success rate, duration, x-ray exposure, and
use of adjuncts for lead extraction all compare favorablyThe Journal of Thoracic and Carwith the literature.25,26,32,33,40 Temporary pacing in
outpatients proved safe, including fully dependent
patients. This form of temporary pacing has been reported
by others with favorable results.31 Hospital stay was 7
days for patients with a pacemaker and 12 days for patients
with an ICD despite a median time to implantation of the
new device of 6 weeks. Others have kept their patients as
inpatients for the antibiotic treatment or because of
a conventional temporary pacing system.2
Patients’ acceptance of the staged procedure was good,
with the majority reporting only minor difficulties with
the external device. This has not been specifically addressed
in the literature. Side effects of the antibiotic treatment
dominated in this context.Limitations
This was a single-center experience. General applicabil-
ity of the results is thus limited. A bias may exist concerning
the rate and severity of device infections because the refer-
ral rate of such patients to tertiary centers has changed
considerably over the years. Thus, there remain a potential
number of patients who receive conservative treatment and
never present to the tertiary referral center. Conversely,
some patients may die before the diagnosis is reached.CONCLUSIONS
Protocol-driven, obligatory, complete removal of all
prosthetic material in any CIED infection is safe and resultsdiovascular Surgery c Volume 142, Number 6 1489
Acquired Cardiovascular Disease Pichlmaier et al
A
C
Din a successful eradication of infection in 98% of patients.
Partial removal, previous lead dislocations, chronic pocket
infection, and poor dental status are highly predictive
for failure to eradicate infection. Interventional lead re-
moval is well tolerated with acceptable low morbidity and
mortality. Interim outpatient treatment of pacemaker-
dependent patients with a temporary, percutaneously exter-
nalized device is also safe and well tolerated by patients and
health care facilities. In this series, neither old age nor sig-
nificant concomitant disease has led to a significant increase
of procedural risk.References
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